首页 > 最新文献

Hpb最新文献

英文 中文
New criteria for preoperative liver function assessment with safety margins to avoid postoperative mortality during liver resection for hilar cholangiocarcinoma 为避免肝门部胆管癌肝切除术中的术后死亡率,制定了具有安全范围的术前肝功能评估新标准。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-02-01 DOI: 10.1016/j.hpb.2024.10.013
Hideaki Kojima , Yuta Abe , Daisuke Udagawa , Koki Hayashi , Naokazu Chiba , Shunichi Imai , Kisyo Mihara , Hisanobu Higashi , Masanori Odaira , Go Oshima , Wataru Koizumi , Minoru Kitago , Hiroshi Yagi , Yasushi Hasegawa , Shutaro Hori , Masayuki Tanaka , Yutaka Nakano , Shigeyuki Kawachi , Yuko Kitagawa

Background

Despite recent medical advancements, surgery for hilar cholangiocarcinoma is associated with high complication and mortality rates. This may be partly attributed to the absence of established preoperative liver evaluation criteria for safe surgery. This study aimed to propose a reliable indicator for safe and well-planned management of major hepatectomy with extrahepatic bile duct resection.

Methods

We included 150 patients who underwent major hepatectomy with extrahepatic bile duct resection between 2013 and 2021 in Japan. The risk factors for post-hepatectomy liver failure (PHLF) were retrospectively analyzed.

Results

PHLF was observed in 24 (16.0 %) patients who underwent major hepatectomy with extrahepatic bile duct resection. In the multivariate analysis, the identified risk factors for PHLF were the ratio of future remnant liver volume to total liver volume (FRLV/TLV) ≤ 42 % and indocyanine green clearance fraction of the future remnant liver (ICGK-F) ≤ 0.07. Patients with these two factors were significantly associated with PHLF compared with those with either one or none of the risk factors (60.0 % vs 15.1 % and 8.1 %, respectively).

Conclusion

The combinational use of ICGK-F and FRLV/TLV is useful for preoperative liver function assessment with a safety margin to avoid PHLF and postoperative mortality in hepatectomy for hilar cholangiocarcinoma.
背景:尽管近年来医疗技术不断进步,但肝门部胆管癌手术的并发症和死亡率仍然很高。其部分原因可能是缺乏安全手术的术前肝脏评估标准。本研究旨在为肝外胆管切除的肝大部切除术的安全和周密计划管理提出一个可靠的指标:我们纳入了 2013 年至 2021 年期间在日本接受肝外胆管大部切除术的 150 例患者。对肝切除术后肝功能衰竭(PHLF)的风险因素进行了回顾性分析:在接受肝外胆管切除术的大肝切除术患者中,有 24 人(16.0%)出现 PHLF。在多变量分析中,确定的 PHLF 风险因素为未来残肝体积与总肝体积之比(FRLV/TLV)≤ 42 % 和未来残肝的吲哚青绿清除率(ICGK-F)≤ 0.07。有这两个因素的患者与只有一个或没有任何风险因素的患者相比,PHLF的发生率明显更高(分别为60.0% vs 15.1%和8.1%):结论:在肝门胆管癌肝切除术中,联合使用 ICGK-F 和 FRLV/TLV 对术前肝功能评估非常有用,可在安全范围内避免 PHLF 和术后死亡率。
{"title":"New criteria for preoperative liver function assessment with safety margins to avoid postoperative mortality during liver resection for hilar cholangiocarcinoma","authors":"Hideaki Kojima ,&nbsp;Yuta Abe ,&nbsp;Daisuke Udagawa ,&nbsp;Koki Hayashi ,&nbsp;Naokazu Chiba ,&nbsp;Shunichi Imai ,&nbsp;Kisyo Mihara ,&nbsp;Hisanobu Higashi ,&nbsp;Masanori Odaira ,&nbsp;Go Oshima ,&nbsp;Wataru Koizumi ,&nbsp;Minoru Kitago ,&nbsp;Hiroshi Yagi ,&nbsp;Yasushi Hasegawa ,&nbsp;Shutaro Hori ,&nbsp;Masayuki Tanaka ,&nbsp;Yutaka Nakano ,&nbsp;Shigeyuki Kawachi ,&nbsp;Yuko Kitagawa","doi":"10.1016/j.hpb.2024.10.013","DOIUrl":"10.1016/j.hpb.2024.10.013","url":null,"abstract":"<div><h3>Background</h3><div>Despite recent medical advancements, surgery for hilar cholangiocarcinoma is associated with high complication and mortality rates. This may be partly attributed to the absence of established preoperative liver evaluation criteria for safe surgery. This study aimed to propose a reliable indicator for safe and well-planned management of major hepatectomy with extrahepatic bile duct resection.</div></div><div><h3>Methods</h3><div>We included 150 patients who underwent major hepatectomy with extrahepatic bile duct resection between 2013 and 2021 in Japan. The risk factors for post-hepatectomy liver failure (PHLF) were retrospectively analyzed.</div></div><div><h3>Results</h3><div>PHLF was observed in 24 (16.0 %) patients who underwent major hepatectomy with extrahepatic bile duct resection. In the multivariate analysis, the identified risk factors for PHLF were the ratio of future remnant liver volume to total liver volume (FRLV/TLV) ≤ 42 % and indocyanine green clearance fraction of the future remnant liver (ICGK-F) ≤ 0.07. Patients with these two factors were significantly associated with PHLF compared with those with either one or none of the risk factors (60.0 % vs 15.1 % and 8.1 %, respectively).</div></div><div><h3>Conclusion</h3><div>The combinational use of ICGK-F and FRLV/TLV is useful for preoperative liver function assessment with a safety margin to avoid PHLF and postoperative mortality in hepatectomy for hilar cholangiocarcinoma.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 2","pages":"Pages 159-166"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjunct mucin biomarkers MUC2+MUC5AC and MUC5AC+PSCA in a clinical setting identify and may improve correct selection of high-risk pancreatic lesions for surgery 临床环境中的辅助粘蛋白生物标志物MUC2+MUC5AC和MUC5AC+PSCA可识别高风险胰腺病变并提高手术选择的正确性。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-02-01 DOI: 10.1016/j.hpb.2024.10.018
Eva Philipson , Karolina Jabbar , Svein-Olav Bratlie , Gunnar Hansson , Jan Persson , Caroline Vilhav , Johanna Wennerblom , Riadh Sadik , Peter Naredi , Johan Bourghardt Fagman , Cecilia Engström

Background

Pancreatic cancer has dismal prognosis with a 5-year survival of 12 %. Cystic lesions have been identified as premalignant lesions. The challenge is to identify lesions with high risk of malignant progression, to offer patients prophylactic curative pancreatic surgery. Previous studies have identified mucin biomarker panels (MUCPs) as potential discriminators of pre- and malignant pancreatic cystic lesions. The present study assessed whether MUCPs contribute to more accurate identification of patients with high-risk pancreatic lesions and improve selection for surgery.

Methods

This retrospective crossover study included 88 patients referred to endoscopic ultrasound because of unclear pancreatic cystic lesions. Clinical management and surgical decision-making with and without MUCP values were assessed by two expert teams with access to patient medical history, radiology, fine-needle aspirates, cytology, and cystic fluid carcinoembryonic antigen.

Results

The adjunct of MUCPs improved decision-making in 2 of 21 cases with surgical pathology, identifying one cancer that otherwise would have been missed and sparing one patient from unnecessary surgery.

Conclusion

Access to MUCPs in a clinical setting improved correct selection of high-risk pancreatic lesions for surgery in single cases. A higher number of incorrect recommendations for surgery with the adjunct of MUCPs was also noted, which calls for caution.
背景:胰腺癌的预后很差,5 年生存率仅为 12%。囊性病变已被确定为癌前病变。目前的挑战是如何识别恶性进展风险高的病变,为患者提供预防性胰腺根治手术。之前的研究发现,粘蛋白生物标记物面板(MUCPs)是鉴别胰腺囊性病变前期和恶性的潜在指标。本研究评估了 MUCPs 是否有助于更准确地识别高危胰腺病变患者并改善手术选择:这项回顾性交叉研究纳入了88名因胰腺囊性病变不明确而转诊至内镜超声检查的患者。由两个专家小组对有无 MUCP 值的临床管理和手术决策进行了评估,这两个专家小组均可获得患者的病史、放射学、细针穿刺、细胞学和囊液癌胚抗原:结果:在 21 例手术病理病例中,MUCP 辅助检查改善了 2 例病例的决策,发现了 1 例可能被漏诊的癌症,使 1 例患者免于不必要的手术:结论:在临床环境中使用 MUCPs 提高了单个病例对高风险胰腺病变手术的正确选择。结论:在临床环境中使用 MUCPs 提高了单个病例中高危胰腺病变手术选择的正确性,但也注意到在使用 MUCPs 的情况下,手术建议的错误率较高,因此需要谨慎。
{"title":"Adjunct mucin biomarkers MUC2+MUC5AC and MUC5AC+PSCA in a clinical setting identify and may improve correct selection of high-risk pancreatic lesions for surgery","authors":"Eva Philipson ,&nbsp;Karolina Jabbar ,&nbsp;Svein-Olav Bratlie ,&nbsp;Gunnar Hansson ,&nbsp;Jan Persson ,&nbsp;Caroline Vilhav ,&nbsp;Johanna Wennerblom ,&nbsp;Riadh Sadik ,&nbsp;Peter Naredi ,&nbsp;Johan Bourghardt Fagman ,&nbsp;Cecilia Engström","doi":"10.1016/j.hpb.2024.10.018","DOIUrl":"10.1016/j.hpb.2024.10.018","url":null,"abstract":"<div><h3>Background</h3><div>Pancreatic cancer has dismal prognosis with a 5-year survival of 12 %. Cystic lesions have been identified as premalignant lesions. The challenge is to identify lesions with high risk of malignant progression, to offer patients prophylactic curative pancreatic surgery. Previous studies have identified mucin biomarker panels (MUCPs) as potential discriminators of pre- and malignant pancreatic cystic lesions. The present study assessed whether MUCPs contribute to more accurate identification of patients with high-risk pancreatic lesions and improve selection for surgery.</div></div><div><h3>Methods</h3><div>This retrospective crossover study included 88 patients referred to endoscopic ultrasound because of unclear pancreatic cystic lesions. Clinical management and surgical decision-making with and without MUCP values were assessed by two expert teams with access to patient medical history, radiology, fine-needle aspirates, cytology, and cystic fluid carcinoembryonic antigen.</div></div><div><h3>Results</h3><div>The adjunct of MUCPs improved decision-making in 2 of 21 cases with surgical pathology, identifying one cancer that otherwise would have been missed and sparing one patient from unnecessary surgery.</div></div><div><h3>Conclusion</h3><div>Access to MUCPs in a clinical setting improved correct selection of high-risk pancreatic lesions for surgery in single cases. A higher number of incorrect recommendations for surgery with the adjunct of MUCPs was also noted, which calls for caution.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 2","pages":"Pages 214-221"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transfusion of irradiated autologous blood for hepatobiliary and pancreatic cancer resections: a feasibility study 输注辐照自体血用于肝胆胰癌切除术的可行性研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-02-01 DOI: 10.1016/j.hpb.2024.11.003
Leyo Ruo, Pablo E. Serrano, Jennifer Ramsay, James J. Hankinson
{"title":"Transfusion of irradiated autologous blood for hepatobiliary and pancreatic cancer resections: a feasibility study","authors":"Leyo Ruo,&nbsp;Pablo E. Serrano,&nbsp;Jennifer Ramsay,&nbsp;James J. Hankinson","doi":"10.1016/j.hpb.2024.11.003","DOIUrl":"10.1016/j.hpb.2024.11.003","url":null,"abstract":"","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 2","pages":"Pages 260-262"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142779029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reoperation for pancreatic fistula: a systematic review of completion pancreatectomy vs. pancreas-preserving-procedures and outcomes 胰腺瘘的再手术:对完全胰腺切除术与保留胰腺的程序和结果的系统回顾。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-02-01 DOI: 10.1016/j.hpb.2024.11.006
Alessio Marchetti , Gaetano Corvino , Giampaolo Perri , Giovani Marchegiani , Raffaele De Luca

Background

Consensus on the nomenclature and indications for reoperation for post-operative pancreatic fistula (POPF) after pancreatoduodenectomy (PD) is lacking. This study explores the available literature to classify the different types of reoperations and report outcomes.

Methods

A systematic literature search was performed, including articles from 2010 to 2024 reporting reoperations for POPF after PD. The primary outcome was 30- or 90-day-mortality. Secondary outcomes included reoperation date, additional relaparotomy, ICU-admission, hospital stay, rate of pancreatic-exocrine-insufficiency, diabetes and long-term survivors.

Results

Twenty-five studies were reviewed with 766 patients reoperated for POPF after PD, 283 (37 %) undergoing completion pancreatectomy (CP) and 483 (63 %) pancreas-preserving-procedures (PPPs). Among PPPs, drainage (30 %), wirsungostomy (14 %), pancreatic anastomosis repair (6 %), “sinking” of pancreatic stump (6 %) and re-do pancreatic anastomosis (4 %) were identified. The main indications for reoperation were post-pancreatectomy hemorrhage, necrotizing acute pancreatitis, sepsis and peritonitis. PPPs were preferred with severe hemodynamic instability. Mortality rates after CP and PPPs ranged from 20 to 56 % and 0–67 %, respectively. Early reoperation was associated with reduced ICU-recovery after “sinking” (p = 0.049).

Conclusion

Reoperation for POPF after PD is rarely needed. When it is, early timing seems critical for better outcomes, and PPPs seems to be the best bail out option in patients with severe hemodynamic instability.
背景:对于胰十二指肠切除术(PD)后再手术胰瘘(POPF)的术语和适应症缺乏共识。本研究以文献为基础,对不同类型的再手术进行分类,并报告手术结果。方法:系统检索2010 ~ 2024年关于PD术后再手术POPF的文献。主要结果是30天或90天死亡率。次要结局包括再手术日期、再次开腹手术、icu入院、住院时间、胰-内分泌功能不全率、糖尿病和长期幸存者。结果:25项研究回顾了766例PD后再手术的POPF患者,283例(37%)接受了完全胰腺切除术(CP), 483例(63%)接受了胰腺保留手术(PPPs)。在PPPs中,引流(30%)、wirsungostomy(14%)、胰腺吻合修复(6%)、胰腺残端“下沉”(6%)和再行胰腺吻合(4%)。再手术指征主要为胰腺切除术后出血、坏死性急性胰腺炎、败血症和腹膜炎。血流动力学不稳定的患者首选PPPs。CP和ppp后的死亡率分别为20% - 56%和0% - 67%。早期再手术与“下沉”后icu恢复率降低相关(p = 0.049)。结论:PD术后POPF再手术较少。如果是这样,早期时机似乎对更好的结果至关重要,ppp似乎是严重血流动力学不稳定患者的最佳救助选择。
{"title":"Reoperation for pancreatic fistula: a systematic review of completion pancreatectomy vs. pancreas-preserving-procedures and outcomes","authors":"Alessio Marchetti ,&nbsp;Gaetano Corvino ,&nbsp;Giampaolo Perri ,&nbsp;Giovani Marchegiani ,&nbsp;Raffaele De Luca","doi":"10.1016/j.hpb.2024.11.006","DOIUrl":"10.1016/j.hpb.2024.11.006","url":null,"abstract":"<div><h3>Background</h3><div>Consensus on the nomenclature and indications for reoperation for post-operative pancreatic fistula (POPF) after pancreatoduodenectomy (PD) is lacking. This study explores the available literature to classify the different types of reoperations and report outcomes.</div></div><div><h3>Methods</h3><div>A systematic literature search was performed, including articles from 2010 to 2024 reporting reoperations for POPF after PD. The primary outcome was 30- or 90-day-mortality. Secondary outcomes included reoperation date, additional relaparotomy, ICU-admission, hospital stay, rate of pancreatic-exocrine-insufficiency, diabetes and long-term survivors.</div></div><div><h3>Results</h3><div>Twenty-five studies were reviewed with 766 patients reoperated for POPF after PD, 283 (37 %) undergoing completion pancreatectomy (CP) and 483 (63 %) pancreas-preserving-procedures (PPPs). Among PPPs, drainage (30 %), wirsungostomy (14 %), pancreatic anastomosis repair (6 %), “sinking” of pancreatic stump (6 %) and re-do pancreatic anastomosis (4 %) were identified. The main indications for reoperation were post-pancreatectomy hemorrhage, necrotizing acute pancreatitis, sepsis and peritonitis. PPPs were preferred with severe hemodynamic instability. Mortality rates after CP and PPPs ranged from 20 to 56 % and 0–67 %, respectively. Early reoperation was associated with reduced ICU-recovery after “sinking” (<em>p</em> = 0.049).</div></div><div><h3>Conclusion</h3><div>Reoperation for POPF after PD is rarely needed. When it is, early timing seems critical for better outcomes, and PPPs seems to be the best bail out option in patients with severe hemodynamic instability.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 2","pages":"Pages 240-249"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142806944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome of a ‘step-up approach’ for recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy after hepato-pancreato-biliary surgery: single center series 肝-胰-胆手术后非狭窄性肝空肠吻合术患者复发性胆管炎的 "升级方法 "疗效:单中心系列研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-02-01 DOI: 10.1016/j.hpb.2024.10.016
Alessandro M. Bonomi , Anouk G. Overdevest , Jeska A. Fritzsche , Olivier R. Busch , Freek Daams , Geert Kazemier , Rutger-Jan Swijnenburg , Ulrich Beuers , Babs M. Zonderhuis , Roy L.J. van Wanrooij , Joris I. Erdmann , Rogier P. Voermans , Marc G. Besselink

Background

Recurrent non-stenotic cholangitis (NSC) is a challenging and poorly understood complication of a surgical hepaticojejunostomy (HJ). Optimal treatment remains unclear.

Methods

A retrospective single center series including patients with recurrent cholangitis with a non-stenotic HJ after hepato-pancreato-biliary surgery was conducted (2015–2022). Primary outcome was resolution of NSC (i.e. free of NSC during six months). Secondary outcomes included reduction of NSC monthly episode frequency and secondary sclerosing cholangitis.

Results

Overall, 50 of 1179 (4.2%) patients with HJ developed NSC. Treatment included a ‘step-up approach’ with short-course antibiotics (n = 50, 100 %), prolonged antibiotics (n = 26, 52%), and revisional surgery (n = 7, 14 %). Resolution of NSC was achieved in 15 patients (30%) and reduction of NSC frequency in an additional 21 patients (42%). Concomitant ursodeoxycholic acid use and discontinuation of proton pump inhibitors was the only predictor for resolution (OR 4.229, p = 0.035). Secondary sclerosing cholangitis occurred in 12 patients (24%) and was associated with the number of NSC episodes (OR 1.2, p = 0.050).

Conclusion

A ‘step-up approach’ to recurrent NSC after HJ resulted in 30 % resolution and further 42 % reduced frequency of NSC although still a quarter of patients developed secondary sclerosing cholangitis. Future prospective studies should assess whether a protocolized approach could improve outcomes.
背景:复发性非狭窄性胆管炎(NSC)是外科肝空肠吻合术(HJ)的一种具有挑战性且鲜为人知的并发症。最佳治疗方法仍不明确:进行了一项回顾性单中心系列研究(2015-2022 年),研究对象包括肝胰胆手术后 HJ 非狭窄的复发性胆管炎患者。主要结果是NSC缓解(即6个月内无NSC)。次要结果包括减少 NSC 每月发作频率和继发性硬化性胆管炎:总的来说,1179 名 HJ 患者中有 50 人(4.2%)出现了 NSC。治疗方法包括使用短程抗生素(50 人,100%)、长程抗生素(26 人,52%)和翻修手术(7 人,14%)的 "渐进方法"。有 15 名患者(30%)的 NSC 得到了缓解,另有 21 名患者(42%)的 NSC 发生率有所下降。同时使用熊去氧胆酸和停用质子泵抑制剂是唯一预测NSC缓解的因素(OR 4.229,P = 0.035)。12名患者(24%)出现了继发性硬化性胆管炎,且与NSC发作次数有关(OR 1.2,p = 0.050):结论:对 HJ 后复发性 NSC 采取 "阶梯式治疗 "可使 30% 的患者病情得到缓解,NSC 的发病率进一步降低了 42%,但仍有四分之一的患者发展为继发性硬化性胆管炎。未来的前瞻性研究应评估规范化方法是否能改善疗效。
{"title":"Outcome of a ‘step-up approach’ for recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy after hepato-pancreato-biliary surgery: single center series","authors":"Alessandro M. Bonomi ,&nbsp;Anouk G. Overdevest ,&nbsp;Jeska A. Fritzsche ,&nbsp;Olivier R. Busch ,&nbsp;Freek Daams ,&nbsp;Geert Kazemier ,&nbsp;Rutger-Jan Swijnenburg ,&nbsp;Ulrich Beuers ,&nbsp;Babs M. Zonderhuis ,&nbsp;Roy L.J. van Wanrooij ,&nbsp;Joris I. Erdmann ,&nbsp;Rogier P. Voermans ,&nbsp;Marc G. Besselink","doi":"10.1016/j.hpb.2024.10.016","DOIUrl":"10.1016/j.hpb.2024.10.016","url":null,"abstract":"<div><h3>Background</h3><div>Recurrent non-stenotic cholangitis (NSC) is a challenging and poorly understood complication of a surgical hepaticojejunostomy (HJ). Optimal treatment remains unclear.</div></div><div><h3>Methods</h3><div>A retrospective single center series including patients with recurrent cholangitis with a non-stenotic HJ after hepato-pancreato-biliary surgery was conducted (2015–2022). Primary outcome was resolution of NSC (i.e. free of NSC during six months). Secondary outcomes included reduction of NSC monthly episode frequency and secondary sclerosing cholangitis.</div></div><div><h3>Results</h3><div>Overall, 50 of 1179 (4.2%) patients with HJ developed NSC. Treatment included a ‘step-up approach’ with short-course antibiotics (n = 50, 100 %), prolonged antibiotics (n = 26, 52%), and revisional surgery (n = 7, 14 %). Resolution of NSC was achieved in 15 patients (30%) and reduction of NSC frequency in an additional 21 patients (42%). Concomitant ursodeoxycholic acid use and discontinuation of proton pump inhibitors was the only predictor for resolution (OR 4.229, p = 0.035). Secondary sclerosing cholangitis occurred in 12 patients (24%) and was associated with the number of NSC episodes (OR 1.2, p = 0.050).</div></div><div><h3>Conclusion</h3><div>A ‘step-up approach’ to recurrent NSC after HJ resulted in 30 % resolution and further 42 % reduced frequency of NSC although still a quarter of patients developed secondary sclerosing cholangitis. Future prospective studies should assess whether a protocolized approach could improve outcomes.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 2","pages":"Pages 177-185"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Original articles: step-by-step decision-making for achieving oncologically acceptable but avoiding over-invasive surgery for gallbladder cancer 原文章:一步一步的决策实现肿瘤可接受,但避免过度侵入胆囊癌手术。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-02-01 DOI: 10.1016/j.hpb.2024.10.014
Kyoji Ito, Yoshikuni Kawaguchi, Yujiro Nishioka, Akinori Miyata, Akihiko Ichida, Nobuhisa Akamatsu, Norihiro Kokudo, Kiyoshi Hasegawa

Background

Gallbladder cancer is a malignancy with a highly dismal prognosis, requiring optimal surgical strategies to achieve effective outcomes. We aimed to evaluate the outcomes of our algorithm-based decision-making approach based on image T-factors and intraoperative pathology of regional lymph node metastases and the bile duct stumps in patients undergoing gallbladder cancer resection.

Methods

A prospectively maintained database of patients who underwent gallbladder cancer resection between April 2001 and June 2022 was reviewed. Our approach included the decision on the extent of local lymph node dissection based on image T-factors and intraoperative rapid pathological diagnosis. The need for extra bile duct resection was decided according to the intraoperative rapid pathological diagnosis of the cystic or bile duct stump.

Results

Overall, 148 patients underwent gallbladder cancer resection and were assessed to evaluate the efficacy of an institutional algorithm-based surgical strategy. Oncologically acceptable surgery rate was 98.6 and 96.9 % in terms of decision-making on the extents of lymph node dissection and bile duct resection, respectively.

Conclusion

Our step-by-step decision-making approach based on image T-factors and intraoperative pathology for gallbladder cancer resection was effective in achieving oncologically acceptable surgeries.
背景:胆囊癌是一种预后非常差的恶性肿瘤,需要最佳的手术策略才能达到有效的预后。我们的目的是评估基于图像t因子和胆囊癌切除术患者区域淋巴结转移和胆管残端术中病理的基于算法的决策方法的结果。方法:回顾了2001年4月至2022年6月期间接受胆囊癌切除术的患者的前瞻性数据库。我们的方法包括根据图像t因子和术中快速病理诊断来决定局部淋巴结清扫的程度。根据术中快速病理诊断胆囊残端或胆管残端,决定是否需要行额外胆管切除。结果:总体而言,148名患者接受了胆囊癌切除术,并评估了基于机构算法的手术策略的有效性。肿瘤可接受手术率在淋巴结清扫程度和胆管切除程度上分别为98.6%和96.9%。结论:我们基于图像t因子和术中病理的一步一步的决策方法可以有效地实现肿瘤可接受的胆囊癌切除术。
{"title":"Original articles: step-by-step decision-making for achieving oncologically acceptable but avoiding over-invasive surgery for gallbladder cancer","authors":"Kyoji Ito,&nbsp;Yoshikuni Kawaguchi,&nbsp;Yujiro Nishioka,&nbsp;Akinori Miyata,&nbsp;Akihiko Ichida,&nbsp;Nobuhisa Akamatsu,&nbsp;Norihiro Kokudo,&nbsp;Kiyoshi Hasegawa","doi":"10.1016/j.hpb.2024.10.014","DOIUrl":"10.1016/j.hpb.2024.10.014","url":null,"abstract":"<div><h3>Background</h3><div>Gallbladder cancer is a malignancy with a highly dismal prognosis, requiring optimal surgical strategies to achieve effective outcomes. We aimed to evaluate the outcomes of our algorithm-based decision-making approach based on image T-factors and intraoperative pathology of regional lymph node metastases and the bile duct stumps in patients undergoing gallbladder cancer resection.</div></div><div><h3>Methods</h3><div>A prospectively maintained database of patients who underwent gallbladder cancer resection between April 2001 and June 2022 was reviewed. Our approach included the decision on the extent of local lymph node dissection based on image T-factors and intraoperative rapid pathological diagnosis. The need for extra bile duct resection was decided according to the intraoperative rapid pathological diagnosis of the cystic or bile duct stump.</div></div><div><h3>Results</h3><div>Overall, 148 patients underwent gallbladder cancer resection and were assessed to evaluate the efficacy of an institutional algorithm-based surgical strategy. Oncologically acceptable surgery rate was 98.6 and 96.9 % in terms of decision-making on the extents of lymph node dissection and bile duct resection, respectively.</div></div><div><h3>Conclusion</h3><div>Our step-by-step decision-making approach based on image T-factors and intraoperative pathology for gallbladder cancer resection was effective in achieving oncologically acceptable surgeries.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 2","pages":"Pages 186-194"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative setting of functional liver volume enhanced by portal and hepatic vein embolization is key in preventing serious morbidity after hepatectomy with bile duct resection for biliary tract cancer 术前门静脉和肝静脉栓塞增强肝功能容量的设置是预防胆道癌肝切除胆管切除术后严重并发症的关键。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-02-01 DOI: 10.1016/j.hpb.2024.11.005
Kenichiro Araki, Akira Watanabe, Takamichi Igarashi, Mariko Tsukagoshi, Norihiro Ishii, Shunsuke Kawai, Kei Hagiwara, Kouki Hoshino, Takaomi Seki, Norifumi Harimoto, Ken Shirabe

Background

The risk of mortality due to serious complications associated with hepatectomy for biliary tract cancer remains high. We aimed to investigate the significance of preoperative functional liver volume in predicting and preventing serious morbidity following hepatectomy with bile duct resection (BDR).

Methods

Seventy-one patients who underwent hepatectomy with BDR for biliary tract cancer were included. Functional future remnant liver volume (fFRLV) was calculated using future liver remnant (FLR) volume and functional score measured using EOB-MRI. Patients with unsatisfactory fFRLV values underwent portal or sequential portal/hepatic vein embolization (PVE/HVE). We assessed relationship between variables for liver-related morbidity (LRM), including posthepatectomy liver failure, bile leakage, and persistent ascites. Additionally, we assessed Clavien-Dindo grade IV complications (CD ≥ IV) as indicators of serious morbidity.

Results

LRM and CD ≥ IV occurred in 20 (28.2 %) and 6 (8.5 %) cases, respectively. Preoperative FLR volume (p = 0.021), FLR ratio (p = 0.004), fFRLV (p = 0.008), and ICGK-F (p = 0.023) were associated with LRM. fFRLV (p = 0.017) was predictive for LRM but not independent (AUC:0.704). Preoperative FLR volume (p = 0.005), FLR ratio (p = 0.008), and fFRLV (p < 0.001) were associated with CD ≥ IV. fFRLV (p = 0.017) was an independent predictive factor for CD ≥ IV(AUC:0.914), showing greater predictive power compared to other factors.

Conclusion

fFRLV predicts CD ≥ IV in patients undergoing hepatectomy with BDR. A sufficient fFRLV, enhanced by PVE/HVE if necessary, may prevent serious morbidity and mortality.
背景:胆道癌肝切除术后因严重并发症而死亡的风险仍然很高。我们的目的是探讨术前功能肝体积在预测和预防肝切除胆管切除术(BDR)后严重并发症中的意义。方法:71例胆道肿瘤行BDR肝切除术的患者。用未来残肝(FLR)体积计算功能性未来残肝体积(fFRLV),用EOB-MRI测量功能评分。fFRLV值不理想的患者接受门静脉或序贯门静脉/肝静脉栓塞(PVE/HVE)。我们评估了肝相关发病率(LRM)变量之间的关系,包括肝切除术后肝衰竭、胆汁漏和持续腹水。此外,我们评估了Clavien-Dindo IV级并发症(CD≥IV)作为严重发病率的指标。结果:LRM和CD≥IV分别发生20例(28.2%)和6例(8.5%)。术前FLR体积(p = 0.021)、FLR比值(p = 0.004)、fFRLV (p = 0.008)、ICGK-F (p = 0.023)与LRM相关。fFRLV (p = 0.017)可预测LRM,但不是独立的(AUC:0.704)。术前FLR体积(p = 0.005)、FLR比值(p = 0.008)和fFRLV (p)结论:fFRLV预测肝切除术合并BDR患者CD≥IV。足够的fFRLV,必要时通过PVE/HVE增强,可以预防严重的发病率和死亡率。
{"title":"Preoperative setting of functional liver volume enhanced by portal and hepatic vein embolization is key in preventing serious morbidity after hepatectomy with bile duct resection for biliary tract cancer","authors":"Kenichiro Araki,&nbsp;Akira Watanabe,&nbsp;Takamichi Igarashi,&nbsp;Mariko Tsukagoshi,&nbsp;Norihiro Ishii,&nbsp;Shunsuke Kawai,&nbsp;Kei Hagiwara,&nbsp;Kouki Hoshino,&nbsp;Takaomi Seki,&nbsp;Norifumi Harimoto,&nbsp;Ken Shirabe","doi":"10.1016/j.hpb.2024.11.005","DOIUrl":"10.1016/j.hpb.2024.11.005","url":null,"abstract":"<div><h3>Background</h3><div>The risk of mortality due to serious complications associated with hepatectomy for biliary tract cancer remains high. We aimed to investigate the significance of preoperative functional liver volume in predicting and preventing serious morbidity following hepatectomy with bile duct resection (BDR).</div></div><div><h3>Methods</h3><div>Seventy-one patients who underwent hepatectomy with BDR for biliary tract cancer were included. Functional future remnant liver volume (fFRLV) was calculated using future liver remnant (FLR) volume and functional score measured using EOB-MRI. Patients with unsatisfactory fFRLV values underwent portal or sequential portal/hepatic vein embolization (PVE/HVE). We assessed relationship between variables for liver-related morbidity (LRM), including posthepatectomy liver failure, bile leakage, and persistent ascites. Additionally, we assessed Clavien-Dindo grade IV complications (CD ≥ IV) as indicators of serious morbidity.</div></div><div><h3>Results</h3><div>LRM and CD ≥ IV occurred in 20 (28.2 %) and 6 (8.5 %) cases, respectively. Preoperative FLR volume (p = 0.021), FLR ratio (p = 0.004), fFRLV (p = 0.008), and ICGK-F (p = 0.023) were associated with LRM. fFRLV (p = 0.017) was predictive for LRM but not independent (AUC:0.704). Preoperative FLR volume (p = 0.005), FLR ratio (p = 0.008), and fFRLV (p &lt; 0.001) were associated with CD ≥ IV. fFRLV (p = 0.017) was an independent predictive factor for CD ≥ IV(AUC:0.914), showing greater predictive power compared to other factors.</div></div><div><h3>Conclusion</h3><div>fFRLV predicts CD ≥ IV in patients undergoing hepatectomy with BDR. A sufficient fFRLV, enhanced by PVE/HVE if necessary, may prevent serious morbidity and mortality.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 2","pages":"Pages 167-176"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic versus open pancreaticoduodenectomy outcomes in patients ≥ 75 years old: an NSQIP analysis of 4343 patients.
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-31 DOI: 10.1016/j.hpb.2025.01.015
Nazgol K Shahbaz, Kevin Verhoeff, Tyrell Wees, Sukhdeep Jatana, Douglas Quan, Juan Glinka, Anton Skaro, Ephraim S Tang

Background: The benefits of MIS in older adults are conflicting. This study evaluates demographics and early outcomes, for older patients (≥75) undergoing minimally invasive (MIS) versus open pancreaticoduodenectomy (PD).

Method: We categorized elderly patients who underwent PD from 2017 to 2021 NSQIP databases by surgical approach (open vs MIS). Baseline characteristics were examined with bivariate analysis, and multivariate logistic regression assessed the independent effect of minimally invasive surgery on 30-day serious complications and mortality.

Results: Amongst 4137 patients, 150 (3.63 %) underwent MIS PD. Patients demographics were similar. Open cohorts were older (79.1 vs 78.4 years; p = 0.011) with greater tumor invasion (36.6 % vs. 27.0 %; p = 0.018). MIS had longer operations (133.1 vs 119.6 min; p < 0.001). Multivariate analysis demonstrated that MIS approach was associated with increased serious complications (OR 2.21; p < 0.001), but not mortality (OR 2.11; p = 0.173). Post hoc analysis excluding cases converted to open demonstrated no difference in serious complications (OR 1.94; p = 0.070) or mortality (OR 3.58; p = 0.094). PSM analysis estimated a 14.7 % higher rate of serious complications in MIS but similar mortality (p = 0.291).

Conclusions: MIS PD uptake in elderly patients remains limited, with early findings indicating longer operations and higher complications. Further research on patient selection differences, technique modifications, and center expertise is required.

{"title":"Laparoscopic versus open pancreaticoduodenectomy outcomes in patients ≥ 75 years old: an NSQIP analysis of 4343 patients.","authors":"Nazgol K Shahbaz, Kevin Verhoeff, Tyrell Wees, Sukhdeep Jatana, Douglas Quan, Juan Glinka, Anton Skaro, Ephraim S Tang","doi":"10.1016/j.hpb.2025.01.015","DOIUrl":"https://doi.org/10.1016/j.hpb.2025.01.015","url":null,"abstract":"<p><strong>Background: </strong>The benefits of MIS in older adults are conflicting. This study evaluates demographics and early outcomes, for older patients (≥75) undergoing minimally invasive (MIS) versus open pancreaticoduodenectomy (PD).</p><p><strong>Method: </strong>We categorized elderly patients who underwent PD from 2017 to 2021 NSQIP databases by surgical approach (open vs MIS). Baseline characteristics were examined with bivariate analysis, and multivariate logistic regression assessed the independent effect of minimally invasive surgery on 30-day serious complications and mortality.</p><p><strong>Results: </strong>Amongst 4137 patients, 150 (3.63 %) underwent MIS PD. Patients demographics were similar. Open cohorts were older (79.1 vs 78.4 years; p = 0.011) with greater tumor invasion (36.6 % vs. 27.0 %; p = 0.018). MIS had longer operations (133.1 vs 119.6 min; p < 0.001). Multivariate analysis demonstrated that MIS approach was associated with increased serious complications (OR 2.21; p < 0.001), but not mortality (OR 2.11; p = 0.173). Post hoc analysis excluding cases converted to open demonstrated no difference in serious complications (OR 1.94; p = 0.070) or mortality (OR 3.58; p = 0.094). PSM analysis estimated a 14.7 % higher rate of serious complications in MIS but similar mortality (p = 0.291).</p><p><strong>Conclusions: </strong>MIS PD uptake in elderly patients remains limited, with early findings indicating longer operations and higher complications. Further research on patient selection differences, technique modifications, and center expertise is required.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143448796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Residency robotic biotissue curriculum: the next frontier in robotic surgical training.
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-31 DOI: 10.1016/j.hpb.2025.01.014
Sarah B Hays, Kristine Kuchta, Aram E Rojas, Syed A Mehdi, Jason L Schwarz, Mark S Talamonti, Melissa E Hogg

Introduction: Virtual reality has been shown to be a strong introduction to the robot. However, we hypothesized that a biotissue curriculum including common surgical anastomoses can further enhance robotic technical skills in surgical residents.

Methods: Post-graduate-year three (PGY-3) general surgery residents completed a two-week robotic simulation rotation. The inanimate exercises used biotissue to simulate common robotic anastomoses, including the running hepaticojejunostomy (RHJ), gastrojejunostomy (GJ), interrupted hepaticojejunostomy (IHJ), and pancreaticojejunostomy (PJ). Drills were timed and graded according to modified Objective Structured Assessment of Technical Skills (OSATS; range 6-30).

Results: 32 residents completed the curriculum. 81.3% of residents reported prior experience at the surgeon console (median=5 operations). Across all drills the average time to completion decreased from first to fourth attempt (RHJ: 33.7±8.9 vs. 26.3±8.1 min, p<0.001; GJ: 57.2±15.1 vs. 44.6±9.5 min, p<0.001; IHJ: 32.6±7.2 vs. 27.1±7.7 min, p<0.001; PJ: 44.2±9.3 vs. 35.6±10.5 min, p<0.001). Average OSATS score increased across all drills as well (RHJ: 16.0±3.8 vs. 23.3±3.4, p<0.001; GJ: 19.4±2.1 vs. 26.0±2.5, p<0.001; IHJ: 16.9±2.7 vs. 23.2±3.6, p<0.001, PJ: 17.9±2.6 vs. 23.6±3.6, p<0.001).

Conclusion: The robotic biotissue curriculum improves resident performance on robotic anastomoses. With the rise of the robotic platform, training in robotic procedures should be incorporated during surgical residency.

{"title":"Residency robotic biotissue curriculum: the next frontier in robotic surgical training.","authors":"Sarah B Hays, Kristine Kuchta, Aram E Rojas, Syed A Mehdi, Jason L Schwarz, Mark S Talamonti, Melissa E Hogg","doi":"10.1016/j.hpb.2025.01.014","DOIUrl":"https://doi.org/10.1016/j.hpb.2025.01.014","url":null,"abstract":"<p><strong>Introduction: </strong>Virtual reality has been shown to be a strong introduction to the robot. However, we hypothesized that a biotissue curriculum including common surgical anastomoses can further enhance robotic technical skills in surgical residents.</p><p><strong>Methods: </strong>Post-graduate-year three (PGY-3) general surgery residents completed a two-week robotic simulation rotation. The inanimate exercises used biotissue to simulate common robotic anastomoses, including the running hepaticojejunostomy (RHJ), gastrojejunostomy (GJ), interrupted hepaticojejunostomy (IHJ), and pancreaticojejunostomy (PJ). Drills were timed and graded according to modified Objective Structured Assessment of Technical Skills (OSATS; range 6-30).</p><p><strong>Results: </strong>32 residents completed the curriculum. 81.3% of residents reported prior experience at the surgeon console (median=5 operations). Across all drills the average time to completion decreased from first to fourth attempt (RHJ: 33.7±8.9 vs. 26.3±8.1 min, p<0.001; GJ: 57.2±15.1 vs. 44.6±9.5 min, p<0.001; IHJ: 32.6±7.2 vs. 27.1±7.7 min, p<0.001; PJ: 44.2±9.3 vs. 35.6±10.5 min, p<0.001). Average OSATS score increased across all drills as well (RHJ: 16.0±3.8 vs. 23.3±3.4, p<0.001; GJ: 19.4±2.1 vs. 26.0±2.5, p<0.001; IHJ: 16.9±2.7 vs. 23.2±3.6, p<0.001, PJ: 17.9±2.6 vs. 23.6±3.6, p<0.001).</p><p><strong>Conclusion: </strong>The robotic biotissue curriculum improves resident performance on robotic anastomoses. With the rise of the robotic platform, training in robotic procedures should be incorporated during surgical residency.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143382355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic review of peritoneal lavage and dialysis for patients with severe acute pancreatitis.
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-31 DOI: 10.1016/j.hpb.2025.01.011
Mikolaj R Kowal, Varuni Bhatnagar, James Pine, Samir Pathak, Andrew Smith, Iestyn Shapey

Aims: Severe acute pancreatitis (SAP) remains a lethal condition with a rising incidence worldwide. Recent randomised trials suggest that peritoneal lavage and/or dialysis (PLD), when administered early in SAP, may be beneficial to improve patient outcomes. This study aimed to review this data systematically.

Methods: Studies featuring PLD for the treatment of SAP were searched systematically (2012 Atlanta classification to 2023). A traditional approach to reporting data was augmented by a narrative synthesis.

Results: 210 articles were reviewed, of which six studies featuring 499 patients were included. The technical approach, duration and type of lavage varied in each study and no safety concerns were reported. In patients undergoing PLD, improvements in inflammatory markers and length of stay were seen in all studies. Where reported, fewer invasive procedures for peri-pancreatic fluid collections were required after PLD. Lower mortality was seen in cohorts receiving laparoscopic lavage alone and combined lavage and dialysis when compared with standard treatment. All studies were rated at moderate or high risk of bias.

Conclusions: PLD demonstrates potential as an early therapy to improve outcomes for patients with SAP. Further research is required to define intervention delivery, explore acceptability and investigate efficacy through a powered randomised controlled trial.

{"title":"Systematic review of peritoneal lavage and dialysis for patients with severe acute pancreatitis.","authors":"Mikolaj R Kowal, Varuni Bhatnagar, James Pine, Samir Pathak, Andrew Smith, Iestyn Shapey","doi":"10.1016/j.hpb.2025.01.011","DOIUrl":"https://doi.org/10.1016/j.hpb.2025.01.011","url":null,"abstract":"<p><strong>Aims: </strong>Severe acute pancreatitis (SAP) remains a lethal condition with a rising incidence worldwide. Recent randomised trials suggest that peritoneal lavage and/or dialysis (PLD), when administered early in SAP, may be beneficial to improve patient outcomes. This study aimed to review this data systematically.</p><p><strong>Methods: </strong>Studies featuring PLD for the treatment of SAP were searched systematically (2012 Atlanta classification to 2023). A traditional approach to reporting data was augmented by a narrative synthesis.</p><p><strong>Results: </strong>210 articles were reviewed, of which six studies featuring 499 patients were included. The technical approach, duration and type of lavage varied in each study and no safety concerns were reported. In patients undergoing PLD, improvements in inflammatory markers and length of stay were seen in all studies. Where reported, fewer invasive procedures for peri-pancreatic fluid collections were required after PLD. Lower mortality was seen in cohorts receiving laparoscopic lavage alone and combined lavage and dialysis when compared with standard treatment. All studies were rated at moderate or high risk of bias.</p><p><strong>Conclusions: </strong>PLD demonstrates potential as an early therapy to improve outcomes for patients with SAP. Further research is required to define intervention delivery, explore acceptability and investigate efficacy through a powered randomised controlled trial.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143407343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hpb
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1